Afasevikumab, CAS 1589503-30-9

Product Description: Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Andrea Chiricozzi, et al. Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential. Psoriasis (Auckl). 2019 May 24;9:29-35.

CAS Number: 1589503-30-9

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related

• SKU: MEXHY-P99424-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99424-1
• Green Labware: No
• Package Unit: 1mg
• Quantity Unit: STK